Proust B, Astier C, Renaudin J M, Magueur E, Maurice D, Belcourt C, Yen F T, Kanny G, Bihain B E, Jacquenet S
Department of Internal Medicine, Clinical Immunology and Allergology, University of Nancy, France.
Eur Ann Allergy Clin Immunol. 2009 Jun;41(3):85-94.
Masked allergens in processed food products can lead to severe allergic reactions following unintentional ingestion. We sought to develop a murine model for the detection of hidden cow's milk proteins (CMP). This study aimed to induce cow's milk allergy in mice, to characterize the anaphylaxis induced by CMP in this model, and to validate its reliability using three margarines manufactured with (A) or without (B, C) milk, sharing the same production line.
Three-week-old BALB/c mice were sensitized intragastrically with CMP plus cholera toxin and boosted 6 times at weekly intervals. CMP-sensitization status was monitored by skin tests, and measurement of CMP-specific IgE and IgG1 levels. On day 44, the minimal threshold of clinical reactivity to CMP in terms of anaphylaxis was determined by performing a dose response of intraperitoneal CMP challenge. Under the same conditions, anaphylaxis was evaluated in CMP-sensitized mice after challenge with protein extracts of margarines A, B or C.
Sensitization to CMP was demonstrated by positive skin tests and increased CMP-specific IgE and IgG1. The minimal clinical reactivity threshold corresponding to 0.1 mg CMP elicited detectable anaphylaxis evidenced by clinical symptoms, a decrease in breathing frequency, and increased plasma histamine upon challenge. Similarly, challenges with margarine A containing CMP demonstrated anaphylaxis, whereas those with B or C did not elicit any detectable allergic reaction.
This study shows that our murine model of CMP-induced anaphylaxis is useful for investigating the allergenic activity and the assessment of margarines with respect to milk.
加工食品中的隐蔽过敏原在意外摄入后可导致严重过敏反应。我们试图建立一种用于检测隐藏牛奶蛋白(CMP)的小鼠模型。本研究旨在使小鼠诱发牛奶过敏,在该模型中表征CMP诱导的过敏反应,并使用在同一生产线上生产的三种含(A)或不含(B、C)牛奶的人造黄油验证其可靠性。
3周龄的BALB/c小鼠通过胃内给予CMP加霍乱毒素进行致敏,并每周加强免疫6次。通过皮肤试验以及测量CMP特异性IgE和IgG1水平来监测CMP致敏状态。在第44天,通过进行腹腔注射CMP激发的剂量反应来确定对CMP过敏反应的最小临床反应阈值。在相同条件下,用A、B或C人造黄油的蛋白提取物激发后,对CMP致敏的小鼠进行过敏反应评估。
皮肤试验阳性以及CMP特异性IgE和IgG1增加表明对CMP致敏。对应于0.1mg CMP的最小临床反应阈值引发了可检测到的过敏反应,表现为临床症状、呼吸频率降低以及激发后血浆组胺增加。同样,用含CMP的人造黄油A激发显示出过敏反应,而用B或C激发未引发任何可检测到的过敏反应。
本研究表明,我们的CMP诱导过敏反应的小鼠模型可用于研究过敏原活性以及评估人造黄油中牛奶的致敏性。